Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Copland

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Current Hematologic Malignancy Reports|June 15, 2019
Is There a Role for Dose Modification of TKI Therapy in CML?M Copland
Pharmacology, Biochemistry, and Behavior|August 1, 1987
The effects of diazepam on brain 5-HT and 5-HIAA in stressed and unstressed ratsA M Copland, D J Balfour
Life Sciences|July 6, 1987
Spontaneous activity and brain 5-hydroxyindole levels measured in rats tested in two designs of elevated X-mazeA M Copland, D J Balfour
Leukemia|October 8, 2013
EZH2 in normal and malignant hematopoiesisK Lund, P D Adams, M Copland
Chest|December 1, 1989
Comparison of outpatient nebulized vs metered dose inhaler terbutaline in chronic airflow obstructionH Mestitz, J M Copland, C F McDonald
Archives of Internal Medicine|September 26, 2001
Oral anticoagulation and hemorrhagic complications in an elderly population with atrial fibrillationM Copland, I D Walker, R C Tait
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|February 12, 1999
Mycobacterial lymphadenitis associated with the initiation of combination antiretroviral therapyP Phillips, M B Kwiatkowski, M Copland, et al.
Australian Veterinary Journal|June 1, 1997
Over representation of Burmese cats with diabetes mellitusJ S Rand, L M Bobbermien, J K Hendrikz, et al.
American Journal of Respiratory and Critical Care Medicine|October 1, 1994
Preoperative risk evaluation for lung cancer resection: predicted postoperative product as a predictor of surgical mortalityR J Pierce, J M Copland, K Sharpe, et al.
Cancer Immunology, Immunotherapy : CII|February 5, 2005
Targeting the silent minority: emerging immunotherapeutic strategies for eradication of malignant stem cells in chronic myeloid leukaemiaM Copland, A R Fraser, S J Harrison, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Current Hematologic Malignancy Reports|June 15, 2019
Is There a Role for Dose Modification of TKI Therapy in CML?M Copland
Pharmacology, Biochemistry, and Behavior|August 1, 1987
The effects of diazepam on brain 5-HT and 5-HIAA in stressed and unstressed ratsA M Copland, D J Balfour
Life Sciences|July 6, 1987
Spontaneous activity and brain 5-hydroxyindole levels measured in rats tested in two designs of elevated X-mazeA M Copland, D J Balfour
Leukemia|October 8, 2013
EZH2 in normal and malignant hematopoiesisK Lund, P D Adams, M Copland
Chest|December 1, 1989
Comparison of outpatient nebulized vs metered dose inhaler terbutaline in chronic airflow obstructionH Mestitz, J M Copland, C F McDonald
Archives of Internal Medicine|September 26, 2001
Oral anticoagulation and hemorrhagic complications in an elderly population with atrial fibrillationM Copland, I D Walker, R C Tait
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|February 12, 1999
Mycobacterial lymphadenitis associated with the initiation of combination antiretroviral therapyP Phillips, M B Kwiatkowski, M Copland, et al.
Australian Veterinary Journal|June 1, 1997
Over representation of Burmese cats with diabetes mellitusJ S Rand, L M Bobbermien, J K Hendrikz, et al.
American Journal of Respiratory and Critical Care Medicine|October 1, 1994
Preoperative risk evaluation for lung cancer resection: predicted postoperative product as a predictor of surgical mortalityR J Pierce, J M Copland, K Sharpe, et al.
Cancer Immunology, Immunotherapy : CII|February 5, 2005
Targeting the silent minority: emerging immunotherapeutic strategies for eradication of malignant stem cells in chronic myeloid leukaemiaM Copland, A R Fraser, S J Harrison, et al.
Pageof 4